#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine tumour of the lung Facioscapulohumeral muscular dystrophy Richter's syndrome Complex regional pain syndrome Cataract Measles Soft tissue necrosis Breast angiosarcoma metastatic Mucopolysaccharidosis III Progressive multifocal leukoencephalopathy Chronic myeloid leukaemia (in remission) Anal cancer Arteriosclerosis Immune-mediated enterocolitis Ewing's sarcoma metastatic More trials…

    Learn about Rare Diseases

    Haemophilia B without inhibitors Urea cycle disorder – Trials in Disease Systemic mastocytosis – Life with Disease Epidermolysis bullosa – Treatment IgA nephropathy – Trials in Disease Focal segmental glomerulosclerosis – Life with Disease Fragile X syndrome – Diagnostics Breast angiosarcoma Behcet’s syndrome – Diagnostics Medulloblastoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tomligisiran Pf-07220060 Monohydrate Odronextamab Radotinib Dihydrochloride Loperamide Hydrochloride Ursodeoxycholic Acid Lamivudine GOVORESTAT Dexamethasone Sodium Phosphate Ciprofloxacin Hydrochloride Messenger Rna Encoding Cas9 Lomustine Eprosartan Mesilate Zimberelimab Alrefimotide Famotidine Gadoquatrane OLVEREMBATINIB Atl001 Idecabtagene Vicleucel More therapies…

    Learn about Your Condition

    Lip and/or oral cavity cancer Myeloproliferative neoplasm Cardiac amyloidosis Stress urinary incontinence Factor VIII deficiency Senile dementia Ependymoma Testicular germ cell cancer Vaginal haemorrhage Optic glioma Diabetic retinal oedema Hypertonic bladder Lymphoedema Hepatitis D Blood disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bronchopulmonary dysplasia

  • Evaluation of Retinol Palmitate Administration and Serum Levels in Preterm Infants with Bronchopulmonary Dysplasia: A Phase 2a Open-Label Study

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    Investigated Drugs:
    • Retinol Palmitate
    Germany Poland
  • Study on Budesonide and Poractant Alfa for Preventing Lung Disease in Very Preterm Infants

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    • Premature baby
    Investigated Drugs:
    • Poractant Alfa
    • Budesonide
    Spain
  • Study on Automatic Oxygen Control for Extremely Preterm Infants Using Oxygen PH.EUR.

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    • Death neonatal
    • Infantile apnoea
    Investigated Drugs:
    • Oxygen Ph.eur.
    Germany
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!